These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 31239156)

  • 61. Transoral robotic surgery and neck dissection alone for head and neck squamous cell carcinoma: Influence of resection margins on oncological outcomes.
    Warner L; O'Hara JT; Lin DJ; Oozeer N; Fox H; Meikle D; Hamilton D; Iqbal MS; Robinson M; Paleri V
    Oral Oncol; 2022 Jul; 130():105909. PubMed ID: 35636080
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Robotic surgery (da Vinci Xi system) in head and neck cancer - own experience.
    Golusiński W; Pieńkowski P; Majchrzak E
    Otolaryngol Pol; 2019 Oct; 74(1):1-5. PubMed ID: 32020902
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Finding/identifying primaries with neck disease (FIND) clinical trial protocol: a study integrating transoral robotic surgery, histopathological localisation and tailored deintensification of radiotherapy for unknown primary and small oropharyngeal head and neck squamous cell carcinoma.
    de Almeida JR; Noel CW; Veigas M; Martino R; Chepeha DB; Bratman SV; Goldstein DP; Hansen AR; Yu E; Metser U; Weinreb I; Perez-Ordonez B; Xu W; Kim J
    BMJ Open; 2019 Dec; 9(12):e035431. PubMed ID: 31892671
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Endoscopic-assisted selective neck dissection via small lateral neck incision for early-stage (T1-2N0M0) head and neck squamous cell carcinoma: 3-year follow-up results.
    Liang F; Fan S; Han P; Cai Q; Lin P; Chen R; Yu S; Huang X
    Surg Endosc; 2017 Feb; 31(2):894-900. PubMed ID: 27369288
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment strategies in early-stage oropharyngeal squamous cell carcinoma: a French national survey.
    Gorphe P; Blanchard P; Morinière S; Fakhry N
    Eur Arch Otorhinolaryngol; 2016 Aug; 273(8):2201-7. PubMed ID: 26253428
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The negative predictive value of FDG PET/CT staging in early oropharyngeal squamous cell carcinoma and implications to transoral robotic surgery patient selection.
    Tapia M; Manji J; Dhillon K; Kleid S; Flatman S; Prasad J; Cardin A; Fua T; Rischin D; Dixon B; J R Magarey M
    Oral Oncol; 2022 Dec; 135():106213. PubMed ID: 36274346
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
    Chen MM; Colevas AD; Megwalu U; Divi V
    Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Is There a Role for Robotic Surgery in the Treatment of Head and Neck Cancer?
    Byrd JK; Ferris RL
    Curr Treat Options Oncol; 2016 Jun; 17(6):29. PubMed ID: 27117980
    [TBL] [Abstract][Full Text] [Related]  

  • 69. TORS for head and neck squamous cell carcinoma (HNSCC): the Hamburg experience.
    Lörincz BB; Knecht R
    B-ENT; 2015; Suppl 24():33-6. PubMed ID: 26891529
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Salvage Transoral Robotic Surgery for Recurrent or Residual Head and Neck Squamous Cell Carcinoma: A Single Institution Experience.
    Dabas S; Dewan A; Ranjan R; Dewan AK; Shukla H; Sinha R
    Asian Pac J Cancer Prev; 2015; 16(17):7627-32. PubMed ID: 26625773
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Trans oral robotic surgery versus definitive chemoradiotherapy for oropharyngeal cancer: 10-year institutional experience.
    Meccariello G; Bianchi G; Calpona S; Parisi E; Cammaroto G; Iannella G; Sgarzani R; Montevecchi F; De Vito A; Capaccio P; Pelucchi S; Vicini C
    Oral Oncol; 2020 Nov; 110():104889. PubMed ID: 32653838
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus-Related Squamous Cell Carcinoma of the Oropharynx.
    Swisher-McClure S; Lukens JN; Aggarwal C; Ahn P; Basu D; Bauml JM; Brody R; Chalian A; Cohen RB; Fotouhi-Ghiam A; Geiger G; Gershowitz J; Livolsi V; Mitra N; Montone K; Newman J; Ojerholm E; O'Malley B; Rajasekaran K; Tan E; Weinstein G; Lin A
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):725-732. PubMed ID: 31785337
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Patient Selection for Transoral Robotic Surgery (TORS) in Oropharyngeal Squamous Cell Carcinoma: What the Surgeon Wants to Know.
    Bunch PM; Patwa HS; Hughes RT; Porosnicu M; Waltonen JD
    Top Magn Reson Imaging; 2021 Apr; 30(2):117-130. PubMed ID: 33828063
    [TBL] [Abstract][Full Text] [Related]  

  • 74. ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.
    Beitler JJ; Quon H; Jones CU; Salama JK; Busse PM; Cooper JS; Koyfman SA; Ridge JA; Saba NF; Siddiqui F; Smith RV; Worden F; Yao M; Yom SS;
    Head Neck; 2016 Sep; 38(9):1299-309. PubMed ID: 27330003
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Transoral robotic surgery for the benefit of patients with head and neck cancer of unknown primary: our experience at St George's University Hospital, London.
    Mistry R; Walker A; Kim D; Ofo E
    Ann R Coll Surg Engl; 2020 Jul; 102(6):442-450. PubMed ID: 32347742
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Decreased gastrostomy tube incidence and weight loss after transoral robotic surgery for low- to intermediate-risk oropharyngeal squamous cell carcinoma.
    Heah H; Goepfert RP; Hutcheson KA; Garden AS; Gunn GB; Fuller CD; Lewin JS; Kupferman ME; Holsinger FC; Hessel AC; Gross ND
    Head Neck; 2018 Nov; 40(11):2507-2513. PubMed ID: 30102824
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Transoral robotic retropharyngeal lymph node dissection with or without lateral oropharyngectomy.
    Byeon HK; Duvvuri U; Kim WS; Park YM; Hong HJ; Koh YW; Choi EC
    J Craniofac Surg; 2013 Jul; 24(4):1156-61. PubMed ID: 23851761
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Role of Transoral Robotic Surgery in the Management of HPV Negative Oropharyngeal Squamous Cell Carcinoma.
    Sload R; Silver N; Jawad BA; Gross ND
    Curr Oncol Rep; 2016 Sep; 18(9):53. PubMed ID: 27469262
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Risk factors for locoregional relapse after transoral robotic surgery for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Funk RK; Moore EJ; García JJ; Harmsen WS; Stoddard DG; Vencio EF; Foote RL; Price KA; Ma DJ
    Head Neck; 2016 Apr; 38 Suppl 1():E1674-9. PubMed ID: 26667985
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Transoral robotic surgery: implementation as a tool in head and neck surgery - a single-centre Australian experience.
    Hirshoren N; Ruskin O; Fua T; Kleid S; Magarey M; Dixon B
    ANZ J Surg; 2018 Nov; 88(11):1129-1134. PubMed ID: 27766718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.